Storia in 19 fonti

Kennedy’s campaign against mRNA vaccines is also a problem for Europe

A recent study by Merck and Moderna, which has yet to be verified, promises surprising results from the use of molecular biology in cancer treatment. Unfortunately, the Trump administration wants to turn this into a political battle

Raccontata da

smh.com.au+7 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

ilfoglio.itStai leggendo1 g fa

Kennedy’s campaign against mRNA vaccines is also a problem for Europe

originale

Timeline cronologica

mercoledì 19 agosto 2026·en.mercopress.com
A personalized mRNA therapy passes a phase 3 melanoma trial for the first time
Pharmaceutical companies Merck, known as MSD outside the United States and Canada, and Moderna announced on Wednesday that their individualized neoantigen therapy, intismeran…
mercoledì 19 agosto 2026·biopharmadive.com
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna…

Kennedy’s campaign against mRNA vaccines is also a problem for Europe

Confronto fonti

Kennedy’s campaign against mRNA vaccines is also a problem for Europe

Timeline cronologica

A personalized mRNA therapy passes a phase 3 melanoma trial for the first time

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma

Merck, Moderna say melanoma vaccine meets goals in large trial | CBC News

Moderna and Merck shares soar on mRNA cancer vaccine

Melanoma, il vaccino personalizzato a mRna supera la fase 3. Un anno fa Kennedy Jr. e l'amministrazione Trump…

mRNA’s second act: A bespoke cancer vaccine & what Merck-Moderna’s melanoma trial could mean for oncology

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in…

‘Breakthrough’ Moderna personalized mRNA cancer vaccine curbs melanoma reoccurrence

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

Merck, Moderna say melanoma vaccine meets goals in large trial | CBC News

‘First time’: Drug giants’ cancer breakthrough

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks…

Melanoma, risultati positivi per il vaccino a mRna (la stessa tecnologia usata contro il Covid) personalizzato

Moderna and Merck shares soar on mRNA cancer vaccine

New Cancer Treatment Hope After mRNA Vaccine Success

Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread

‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say

Moderna shares nearly triple on skin cancer vaccine success

New Melanoma Vaccine Shows Promise In Fighting Cancer, Preventing Recurrence

Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments?

Moderna, Merck breakthrough could usher in a wave of cancer vaccines

Doctors explain how Moderna's melanoma mRNA vaccine could fight deadliest form of skin cancer

‘Breakthrough’ mRNA cancer drug curbs melanoma in large trial

mRNA’s second act: A bespoke cancer vaccine & what Merck-Moderna’s melanoma trial could mean for oncology

First personalized mRNA cancer vaccine succeeds in Phase 3 trial